THRD - Third Harmonic Bio, Inc Sotuvning sof marjinal rentabelligi

Third Harmonic Bio Inc. (THRD) korporativ emblemasi va logotipi

Third Harmonic Bio (THRD) aksiyalar narxlarining o'sishi urtikariya uchun KIT inhibitorining 2-bosqich sinovlari natijalariga bog'liq. Sof foyda marjasi tendentsiyasi joriy operatsion samaradorlikni namoyish etadi, bunda ushbu ko'rsatkich 0.00 ga teng. Strategiya immun tizimi bilan bog'liq dori vositalarini ishlab chiqish uchun ilmiy markazlar bilan hamkorlikka asoslangan. Biroq, resurslarning yagona oral mahsulotga yuqori konsentratsiyasi investorlar uchun o'ziga xos binar xatarlarni yuzaga keltiradi.

Third Harmonic Bio Inc (THRD) Sof foyda normasi: 28.04.2023 - 16.08.2025 davri uchun

Third Harmonic Bio, Inc (THRD) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning jamlanma tahliliyoti:thirdharmonicbio.com - THRD
Third Harmonic Bio Inc. tayyor mahsulotlari

Third Harmonic Bio (THRD) tadqiqot va ishlanmalar komplekslarining rejalashtirilgan quvvatdan foydalanish darajasi joriy sinov bosqichlari uchun molekulalarning barqaror sintezini ta'minlaydi. Daromad ichidagi sof marjani tahlil qilish orqali investor barcha operatsion va soliq xarajatlarini qoplashdan keyin qolgan foyda qismini aniqlaydi. Ushbu ko'rsatkich narxlardagi shovqinni biznesning fundamental samaradorligining aniq signaliga aylantiradi. Ushbu metrikadagi ijobiy dinamika sertifikatlangan quvvatlar uchun xarajatlarning optimallashtirilganligini tasdiqlaydi. Rentabellikning oshishi aksiya narxining pasayishi xavfini minimallashtirib, emitentning bozordagi barqarorligini mustahkamlaydi.

Raqobatchilar tahlili

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Sof foyda normasi|Adicet Bio, Inc. - Sotuvning sof rentabelligi|Celularity Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi INmune Bio Corporation INMB|Barinthus Biotherapeutics - Sotuvning sof marjinal rentabelligi|Kezar Life Sciences, Inc. (KZR) - Sof foyda bo'yicha sotuv rentabelligi|SAB Biotherapeutics Inc. (SABS) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi Akari Therapeutics plc|Sof marja enlivex.com|q32bio.com (QTTB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi GOVX|Edesa Biotech, Inc. - Sotuvning sof rentabelligi|iBio Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Carisma Therapeutics CARM|XTLB - Sof marja|BOLT (boltbio.com) - Sotuvning sof rentabelligi|HCWB: Sotuvning sof marjinal rentabelligi|Aptevo (APVO) - Sotuvning sof marjinal rentabelligi|Sof marja AIM ImmunoTech|Sof foyda bo'yicha sotuv rentabelligi Aditxt (ADTX)|Sof foyda bo'yicha sotuv rentabelligi GRI (GRI Bio Corporation)|XORTX - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi HIND (Vyome Holdings Inc.)|Sof foyda normasi REVB|Indaptus - Sotuvning sof marjinal rentabelligi|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning sof rentabelligi|CALI: Sotuvning sof marjinal rentabelligi|Affimed NV - Sof foyda normasi|Sof marja Allakos Inc.|Sotuvning sof marjinal rentabelligi HOOKIPA Pharma|Sof marja IGM Biosciences, Inc. (IGMS)|ITOS - Sof marja|Sotuvning sof marjinal rentabelligi OCEA (Ocean Bio)|Sof foyda normasi TCBP